Anti-Thymocyte Globulin Induces Neoangiogenesis and Preserves Cardiac Function after Experimental Myocardial Infarction
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Anti-Thymocyte Globulin Induces Neoangiogenesis and Preserves Cardiac Function after Experimental Myocardial Infarction
Authors
Keywords
-
Journal
PLoS One
Volume 7, Issue 12, Pages e52101
Publisher
Public Library of Science (PLoS)
Online
2012-12-21
DOI
10.1371/journal.pone.0052101
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ex Vivo Expansion of Human Tregs by Rabbit ATG Is Dependent on Intact STAT3-Signaling in CD4+ T Cells and Requires the Presence of Monocytes
- (2012) O. Boenisch et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Intravenous and intramyocardial injection of apoptotic white blood cell suspensions prevents ventricular remodelling by increasing elastin expression in cardiac scar tissue after myocardial infarction
- (2011) Michael Lichtenauer et al. BASIC RESEARCH IN CARDIOLOGY
- Anti-T Lymphocyte Globulin (ATG) Induces Generation of Regulatory T Cells, at Least Part of Them Express Activated CD44
- (2011) Orly Shimony et al. JOURNAL OF CLINICAL IMMUNOLOGY
- CCR5 Signaling Suppresses Inflammation and Reduces Adverse Remodeling of the Infarcted Heart, Mediating Recruitment of Regulatory T Cells
- (2010) Marcin Dobaczewski et al. AMERICAN JOURNAL OF PATHOLOGY
- Paracrine factors secreted by endothelial progenitor cells prevent oxidative stress-induced apoptosis of mature endothelial cells
- (2010) Zijiang Yang et al. ATHEROSCLEROSIS
- Oestrogen prevents cardiomyocyte apoptosis by suppressing p38α-mediated activation of p53 and by down-regulating p53 inhibition on p38β
- (2010) Han Liu et al. CARDIOVASCULAR RESEARCH
- Monocytes: Protagonists of Infarct Inflammation and Repair After Myocardial Infarction
- (2010) Matthias Nahrendorf et al. CIRCULATION
- Inhibition of p53 after acute myocardial infarction: Reduction of apoptosis is counteracted by disturbed scar formation and cardiac rupture
- (2010) Ying Zhang et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- A New Monocyte Chemotactic Protein-1/Chemokine CC Motif Ligand-2 Competitor Limiting Neointima Formation and Myocardial Ischemia/Reperfusion Injury in Mice
- (2010) Elisa A. Liehn et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Improved left ventricular function after transplantation of microspheres and fibroblasts in a rat model of myocardial infarction
- (2009) Alexander Schuh et al. BASIC RESEARCH IN CARDIOLOGY
- Intracoronary bone marrow cell transfer after myocardial infarction: 5-year follow-up from the randomized-controlled BOOST trial
- (2009) G. P. Meyer et al. EUROPEAN HEART JOURNAL
- Irradiated cultured apoptotic peripheral blood mononuclear cells regenerate infarcted myocardium
- (2009) H. J. Ankersmit et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- VEGF Gene Therapy Fails to Improve Perfusion of Ischemic Myocardium in Patients With Advanced Coronary Disease: Results of the NORTHERN Trial
- (2009) Duncan J Stewart et al. MOLECULAR THERAPY
- Novel Cell-Free Strategy for Therapeutic Angiogenesis: In Vitro Generated Conditioned Medium Can Replace Progenitor Cell Transplantation
- (2009) Stefano Di Santo et al. PLoS One
- Long-Term Trends in the Incidence of Heart Failure After Myocardial Infarction
- (2008) Raghava S. Velagaleti et al. CIRCULATION
- Paracrine Mechanisms in Adult Stem Cell Signaling and Therapy
- (2008) Massimiliano Gnecchi et al. CIRCULATION RESEARCH
- Bone marrow cells are a rich source of growth factors and cytokines: implications for cell therapy trials after myocardial infarction
- (2008) Mortimer Korf-Klingebiel et al. EUROPEAN HEART JOURNAL
- Coronary collaterals: The role of MCP-1 during the early phase of acute myocardial infarction
- (2008) Hun-Jun Park et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started